In a published Phase 2 trial (48 weeks), adults with obesity who took retatrutide lost, on average, more weight at higher doses, with the 12 mg group showing 24.2% average weight change at 48 weeks (compared with 2.1% in the placebo group)
A consultation with our clinical team will help determine whether Wegovy is the right option for you
Do you want to increase your mental alertness
Can you exercise while taking Retatrutide
Nausea, vomiting, and diarrhea, which occur in 20-40% of patients initiating these medications, can lead to dehydration and reduced kidney perfusion if fluid intake is inadequate
If you suspect you may have PAD, ask your doctor about getting tested